We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+3.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$2.41B
AUM Growth
+$32.9M
Cap. Flow
+$54.2M
Cap. Flow %
2.25%
Top 10 Hldgs %
24.11%
Holding
705
New
310
Increased
110
Reduced
100
Closed
162

Sector Composition

Rank Sector Weight
1 Healthcare 16.42%
2 Consumer Discretionary 12.55%
3 Technology 11.96%
4 Financials 11.48%
5 Communication Services 10.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSC icon
501
Norfolk Southern
NSC
$78.8B
$232K 0.01%
+1,705
New +$245K
LNTH icon
502
Lantheus
LNTH
$6.82B
$231K 0.01%
+14,500
New +$283K
XLP icon
503
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.2B
$229K 0.01%
+4,359
New +$240K
AGIO icon
504
Agios Pharmaceuticals
AGIO
$2.16B
$227K 0.01%
+2,774
New +$214K
EGRX
505
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$227K 0.01%
+4,300
New +$250K
DIA icon
506
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.8B
$226K 0.01%
+936
New +$235K
CACI icon
507
CACI
CACI
$10.8B
$222K 0.01%
+1,470
New +$215K
ON icon
508
ON Semiconductor
ON
$33.8B
$222K 0.01%
+9,073
New +$219K
CYTK icon
509
Cytokinetics
CYTK
$11B
$220K 0.01%
+30,600
New +$262K
HAE icon
510
Haemonetics
HAE
$3.58B
$220K 0.01%
+3,013
New +$207K
ARNA
511
DELISTED
Arena Pharmaceuticals Inc
ARNA
$219K 0.01%
+5,538
New +$215K
RETA
512
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$217K 0.01%
+10,600
New +$273K
AXDX
513
DELISTED
Accelerate Diagnostics
AXDX
$213K 0.01%
+930
New +$244K
CRSP icon
514
CRISPR Therapeutics
CRSP
$4.58B
$212K 0.01%
+4,627
New +$191K
EOG icon
515
EOG Resources
EOG
$78B
$212K 0.01%
+2,017
New +$217K
HOME
516
DELISTED
At Home Group Inc.
HOME
$211K 0.01%
+6,600
New +$203K
XEC
517
DELISTED
CIMAREX ENERGY CO
XEC
$210K 0.01%
2,244
-29,313
-93% -$3.12M
VRAY
518
DELISTED
ViewRay, Inc.
VRAY
$208K 0.01%
+32,400
New +$270K
EMWP
519
DELISTED
Eros Media World PLC
EMWP
$207K 0.01%
+950
New +$226K
KURA icon
520
Kura Oncology
KURA
$922M
$206K 0.01%
+11,000
New +$214K
WB icon
521
Weibo
WB
$1.9B
$202K 0.01%
+1,693
New +$216K
BAS
522
DELISTED
Basis Energy Services, Inc.
BAS
$199K 0.01%
+13,800
New +$267K
BBD icon
523
Banco Bradesco
BBD
$38.1B
$178K 0.01%
+26,322
New +$176K
PRPLW
524
DELISTED
Purple Innovation, Inc.
PRPLW
$178K 0.01%
+200,000
New +$197K
TELL
525
DELISTED
Tellurian Inc.
TELL
$177K 0.01%
+24,600
New +$236K

Similar funds

Marshall Wace's Q1 2018 Portfolio in Review

As of Q1 2018, Marshall Wace held 705 positions worth $2.41B, up 1.4% from $2.38B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Marshall Wace's Q1 2018 filing shows 310 new, 110 increased, 100 reduced and 162 closed positions. Its largest new stake was Avista: 402,414 shares worth $20.6M. The largest sale was Alphabet (Google) Class A, an estimated $89.2M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Marshall Wace's largest Q1 2018 buy was Avista: 402,414 shares worth $20.6M.
  • Marshall Wace added most to Alibaba in Q1 2018, an estimated $88.8M increase.
  • Marshall Wace's biggest Q1 2018 reduction was Alphabet (Google) Class A, cutting an estimated $89.2M.
  • Marshall Wace fully exited Logitech in Q1 2018, selling an estimated $74.8M.
  • Marshall Wace's ten largest holdings make up 24% of its $2.41B portfolio in Q1 2018.
  • Marshall Wace opened 310 new positions and closed 162 in Q1 2018.
  • Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $2.41B.

Based on Marshall Wace's 13F filing for Q1 2018, filed 15 May 2018.